These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 5708129)

  • 1. Properties of microsomal activator of profibrinolysin found in bovine and porcine heart muscle.
    Nakahara M; Celander DR
    Thromb Diath Haemorrh; 1968 Jul; 19(3):483-91. PubMed ID: 5708129
    [No Abstract]   [Full Text] [Related]  

  • 2. [Method of isolating and studying the properties of plasminogen tissue activator (profibrinolysin)].
    Andreenko GV; Migalina LA
    Biokhimiia; 1971; 36(4):685-9. PubMed ID: 5095950
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity-pH relationship and Michaelis constants during activation of profibrinolysin and during fibrinogenolysis.
    Nanninga LB; Guest MM
    Thromb Diath Haemorrh; 1968 Jul; 19(3):492-8. PubMed ID: 4236823
    [No Abstract]   [Full Text] [Related]  

  • 4. Isolation and purification of highly enriched tissue plasminogen activator from pig heart.
    Rickli EE; Zaugg H
    Thromb Diath Haemorrh; 1970 Feb; 23(1):64-76. PubMed ID: 5420435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Measurement of the fibrinolytic activation capacity of urine. Description of a simplified method. Role of ions].
    Kahn JP; Verbanck M
    Pathol Biol (Paris); 1973 Apr; 21(4):339-47. PubMed ID: 4576171
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of ribonucleic acid with structural proteins.
    Mattioli A; Montanaro L; Sperti S
    Arch Sci Biol (Bologna); 1967; 51(3):235-40. PubMed ID: 5593451
    [No Abstract]   [Full Text] [Related]  

  • 8. Heart proteins, in situ dissolution of myofibrillar actomyosin in bovine heart.
    Hocman G; Bózner A; Baláz V; Bozdĕchová A
    Biochem Exp Biol; 1978; 14(2):115-7. PubMed ID: 223609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of porcine blood clots to lysis relates to poor activation of porcine plasminogen by tissue plasminogen activator.
    Flight SM; Masci PP; Lavin MF; Gaffney PJ
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):417-20. PubMed ID: 16788320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and characterization of recombinant porcine plasminogen activator inhibitor-1.
    Bijnens AP; Knockaert I; Cousin E; Kruithof EK; Declerck PJ
    Thromb Haemost; 1997 Feb; 77(2):350-6. PubMed ID: 9157595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombolytic activity of BB-10153, a thrombin-activatable plasminogen.
    Comer MB; Cackett KS; Gladwell S; Wood LM; Dawson KM
    J Thromb Haemost; 2005 Jan; 3(1):146-53. PubMed ID: 15634278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinolytic properties and thrombolytic effect of a novel fibrinolytic enzyme from Streptomyces sp. Y405].
    Wang M; Wang J; Shao M; Wang M; Wang Y
    Yao Xue Xue Bao; 1998 Jul; 33(7):481-5. PubMed ID: 12016879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The heparin--tissue plasminogen activator complex and some of its properties].
    Shimonaeva EE; Shimonaev GS; Aleshina TS
    Biokhimiia; 1983 Oct; 48(10):1687-90. PubMed ID: 6685533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stress induced release of plasminogen activator from lysosomes.
    Beard EL; Busuttil RW; Gottshalk SK
    Thromb Diath Haemorrh; 1969 Feb; 21(1):20-5. PubMed ID: 5773727
    [No Abstract]   [Full Text] [Related]  

  • 15. A refined kinetic analysis of plasminogen activation by recombinant bovine tissue-type plasminogen activator indicates two interconvertible activator forms.
    Johnsen LB; Ravn P; Berglund L; Petersen TE; Rasmussen LK; Heegaard CW; Rasmussen JT; Benfeldt C; Fedosov SN
    Biochemistry; 1998 Sep; 37(36):12631-9. PubMed ID: 9730836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Freeze-dried fibrinogen or fibrinogen in EDTA stimulate the tissue-type plasminogen activator-catalysed conversion of plasminogen to plasmin.
    Haddeland U; Sletten K; Bennick A; Brosstad F
    Blood Coagul Fibrinolysis; 1994 Aug; 5(4):575-81. PubMed ID: 7841314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage.
    Hua Y; Xi G; Keep RF; Wu J; Jiang Y; Hoff JT
    J Cereb Blood Flow Metab; 2002 Jan; 22(1):55-61. PubMed ID: 11807394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of the fibrin agar plate for measurements of the components of the fibrinolytic system. I. The measurement of plasminogen (on type I fibrin agar plates).
    Wolf P
    Thromb Diath Haemorrh; 1968 Nov; 20(1):50-65. PubMed ID: 5708899
    [No Abstract]   [Full Text] [Related]  

  • 20. An improved purification protocol for heart and skeletal muscle calpastatin reveals two isoforms resulting from alternative splicing.
    Geesink GH; Nonneman D; Koohmaraie M
    Arch Biochem Biophys; 1998 Aug; 356(1):19-24. PubMed ID: 9681986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.